Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

Anthill Agency launch digital-focused academy

Partners with Actando’s PharmAcademy to boost pharma’s digital skills

- PMLiVE

Eisai to tackle dementia in new US research facility

Aims to introduce a new compound into the clinic by 2020

- PMLiVE

AMICULUM launch specialist agency

Seques will be led by Jenny Szkolar and Patricia Jones

- PMLiVE

Sage surges after depression drug gets rapid path to approval

Will be able to file a marketing application based on its phase II trial

Weekly comms appointments

Publicis Resolute, Road and W2O all add to their teams

- PMLiVE

UK, Germany back routine use of J&J’s Tremfya

The IL-23 inhibitor is currently being assessed in other EU countries

- PMLiVE

Revenue down the back of the beanbag

How to engage with employees to create a sophisticated strategy

Australian Flu and the dilemma of naming diseases

During the winter of 2017-2018 not a day passed when the Australian flu was not mentioned by the UK press. The British media turned talking about Australian flu into an...

Say Communications

- PMLiVE

Health Unlimited bolsters PR team

Appoints Ann Bartling as PR practice lead

- PMLiVE

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

A rapid round up of today's pharma, biotech and healthcare news

- PMLiVE

GSK’s vaccines president Debruyne heads for the exit

Roger Connor to take on the role in latest shake up

- PMLiVE

AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib

Patients with RA reported an improvement in mobility pain on the JAK1 inhibitor

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links